ABS.OL
Price:
$3.87
Market Cap:
$103.95M
Arctic Bioscience AS, a biotechnology company, develops and commercializes pharmaceutical and nutraceutical products. Its development stage product candidate is HRO350, a novel oral treatment for mild-to-moderate psoriasis. The company sells its nutraceuticals as bulk ingredients to other companies under the ROMEGA brand worldwide. Arctic Bioscience AS was incorporated in 2011 and is based in Ørsta, Norway.
Industry
Biotechnology
IPO Date
2021-02-24
Stock Exchange
OSL
Ticker
ABS.OL
According to Arctic Bioscience AS’s latest financial reports and current stock price. The company's current Current Ratio is 0.83. This represents a change of -53.45% compared to the average of 1.77 of the last 4 quarters.
The mean historical Current Ratio of Arctic Bioscience AS over the last ten years is 4.36. The current 0.83 Current Ratio has changed 1.79% with respect to the historical average. Over the past ten years (40 quarters), ABS.OL's Current Ratio was at its highest in in the December 2021 quarter at 12.76. The Current Ratio was at its lowest in in the June 2025 quarter at 0.83.
Average
4.36
Median
3.36
Minimum
0.86
Maximum
12.76
Discovering the peaks and valleys of Arctic Bioscience AS Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 449.96%
Maximum Annual Current Ratio = 12.76
Minimum Annual Increase = -74.48%
Minimum Annual Current Ratio = 0.86
| Year | Current Ratio | Change |
|---|---|---|
| 2024 | 0.86 | -74.48% |
| 2023 | 3.36 | -31.55% |
| 2022 | 4.91 | -61.55% |
| 2021 | 12.76 | 449.96% |
| 2020 | 2.32 | -51.09% |
| 2019 | 4.74 | 201.38% |
The current Current Ratio of Arctic Bioscience AS (ABS.OL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.04
5-year avg
4.84
10-year avg
4.36
Arctic Bioscience AS’s Current Ratio is less than Airthings ASA (2.44), less than BerGenBio ASA (4.39), less than Huddly AS (2.16),
| Company | Current Ratio | Market cap |
|---|---|---|
| 2.44 | $38.59M | |
| 4.39 | $45.74M | |
| 2.16 | $342.10M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arctic Bioscience AS using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Arctic Bioscience AS or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Arctic Bioscience AS's Current Ratio?
How is the Current Ratio calculated for Arctic Bioscience AS (ABS.OL)?
What is the highest Current Ratio for Arctic Bioscience AS (ABS.OL)?
What is the 3-year average Current Ratio for Arctic Bioscience AS (ABS.OL)?
What is the 5-year average Current Ratio for Arctic Bioscience AS (ABS.OL)?
How does the current Current Ratio for Arctic Bioscience AS (ABS.OL) compare to its historical average?